[1]
“Repurposing drugs as uS12 ribosomal protein inhibitors to overcome UTI resistance in MDR Pseudomonas strains: In silico and in vitro study”, IJBB, vol. 61, no. 11, pp. 672–687, Oct. 2024, doi: 10.56042/ijbb.v61i11.8728.